The CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) has announced intentions to award a sole source Blanket Purchase Agreement (BPA) with Illumina, Inc.
The BPA is for next generation library preparation, instrumentation, product care plans, and sequencing reagents/consumables. The consumables are in a pre-configured format which fit directly into the cBOT, HiSeq, MiSeq and NextSeq Next Generation Sequencing Instruments in use by the researchers in the lab.
“The continued use of Illumnia Inc. platform is required to assure continuity of research within the labs in which considerable amounts of data have already been accumulated using this sequencing platform,” states the announcement. “Ordering from another source would compromise experiments and compromise the integrity of data.”